Global Osimertinib Drugs Market Growth 2023-2029

March 2023 | 75 pages | ID: G7211D60BFD8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.

LPI (LP Information)' newest research report, the “Osimertinib Drugs Industry Forecast” looks at past sales and reviews total world Osimertinib Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Osimertinib Drugs sales for 2023 through 2029. With Osimertinib Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osimertinib Drugs industry.

This Insight Report provides a comprehensive analysis of the global Osimertinib Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osimertinib Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Osimertinib Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osimertinib Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osimertinib Drugs.

The global Osimertinib Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Osimertinib Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Osimertinib Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Osimertinib Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Osimertinib Drugs players cover AstraZeneca. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 40mg
• 80mg

Segmentation by application

• Hospital
• Drugs Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca

Key Questions Addressed in this Report

What is the 10-year outlook for the global Osimertinib Drugs market?

What factors are driving Osimertinib Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Osimertinib Drugs market opportunities vary by end market size?

How does Osimertinib Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Osimertinib Drugs Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Osimertinib Drugs by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Osimertinib Drugs by Country/Region, 2018, 2022 & 2029
2.2 Osimertinib Drugs Segment by Type
  2.2.1 40mg
  2.2.2 80mg
2.3 Osimertinib Drugs Sales by Type
  2.3.1 Global Osimertinib Drugs Sales Market Share by Type (2018-2023)
  2.3.2 Global Osimertinib Drugs Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Osimertinib Drugs Sale Price by Type (2018-2023)
2.4 Osimertinib Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
2.5 Osimertinib Drugs Sales by Application
  2.5.1 Global Osimertinib Drugs Sale Market Share by Application (2018-2023)
  2.5.2 Global Osimertinib Drugs Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Osimertinib Drugs Sale Price by Application (2018-2023)

3 GLOBAL OSIMERTINIB DRUGS BY COMPANY

3.1 Global Osimertinib Drugs Breakdown Data by Company
  3.1.1 Global Osimertinib Drugs Annual Sales by Company (2018-2023)
  3.1.2 Global Osimertinib Drugs Sales Market Share by Company (2018-2023)
3.2 Global Osimertinib Drugs Annual Revenue by Company (2018-2023)
  3.2.1 Global Osimertinib Drugs Revenue by Company (2018-2023)
  3.2.2 Global Osimertinib Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Osimertinib Drugs Sale Price by Company
3.4 Key Manufacturers Osimertinib Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Osimertinib Drugs Product Location Distribution
  3.4.2 Players Osimertinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR OSIMERTINIB DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Osimertinib Drugs Market Size by Geographic Region (2018-2023)
  4.1.1 Global Osimertinib Drugs Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Osimertinib Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Osimertinib Drugs Market Size by Country/Region (2018-2023)
  4.2.1 Global Osimertinib Drugs Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Osimertinib Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Osimertinib Drugs Sales Growth
4.4 APAC Osimertinib Drugs Sales Growth
4.5 Europe Osimertinib Drugs Sales Growth
4.6 Middle East & Africa Osimertinib Drugs Sales Growth

5 AMERICAS

5.1 Americas Osimertinib Drugs Sales by Country
  5.1.1 Americas Osimertinib Drugs Sales by Country (2018-2023)
  5.1.2 Americas Osimertinib Drugs Revenue by Country (2018-2023)
5.2 Americas Osimertinib Drugs Sales by Type
5.3 Americas Osimertinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Osimertinib Drugs Sales by Region
  6.1.1 APAC Osimertinib Drugs Sales by Region (2018-2023)
  6.1.2 APAC Osimertinib Drugs Revenue by Region (2018-2023)
6.2 APAC Osimertinib Drugs Sales by Type
6.3 APAC Osimertinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Osimertinib Drugs by Country
  7.1.1 Europe Osimertinib Drugs Sales by Country (2018-2023)
  7.1.2 Europe Osimertinib Drugs Revenue by Country (2018-2023)
7.2 Europe Osimertinib Drugs Sales by Type
7.3 Europe Osimertinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Osimertinib Drugs by Country
  8.1.1 Middle East & Africa Osimertinib Drugs Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Osimertinib Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Osimertinib Drugs Sales by Type
8.3 Middle East & Africa Osimertinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osimertinib Drugs
10.3 Manufacturing Process Analysis of Osimertinib Drugs
10.4 Industry Chain Structure of Osimertinib Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Osimertinib Drugs Distributors
11.3 Osimertinib Drugs Customer

12 WORLD FORECAST REVIEW FOR OSIMERTINIB DRUGS BY GEOGRAPHIC REGION

12.1 Global Osimertinib Drugs Market Size Forecast by Region
  12.1.1 Global Osimertinib Drugs Forecast by Region (2024-2029)
  12.1.2 Global Osimertinib Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Osimertinib Drugs Forecast by Type
12.7 Global Osimertinib Drugs Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Information
  13.1.2 AstraZeneca Osimertinib Drugs Product Portfolios and Specifications
  13.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 AstraZeneca Main Business Overview
  13.1.5 AstraZeneca Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Osimertinib Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Osimertinib Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 80mg
Table 5. Global Osimertinib Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Osimertinib Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Osimertinib Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Osimertinib Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Osimertinib Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Osimertinib Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global Osimertinib Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Osimertinib Drugs Revenue by Application (2018-2023)
Table 13. Global Osimertinib Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Osimertinib Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Osimertinib Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global Osimertinib Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Osimertinib Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Osimertinib Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Osimertinib Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Osimertinib Drugs Producing Area Distribution and Sales Area
Table 21. Players Osimertinib Drugs Products Offered
Table 22. Osimertinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Osimertinib Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Osimertinib Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Osimertinib Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Osimertinib Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Osimertinib Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Osimertinib Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Osimertinib Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Osimertinib Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas Osimertinib Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Osimertinib Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Osimertinib Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Osimertinib Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas Osimertinib Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC Osimertinib Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC Osimertinib Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Osimertinib Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Osimertinib Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Osimertinib Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC Osimertinib Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe Osimertinib Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Osimertinib Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Osimertinib Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Osimertinib Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe Osimertinib Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Osimertinib Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Osimertinib Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Osimertinib Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Osimertinib Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Osimertinib Drugs
Table 58. Key Market Challenges & Risks of Osimertinib Drugs
Table 59. Key Industry Trends of Osimertinib Drugs
Table 60. Osimertinib Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Osimertinib Drugs Distributors List
Table 63. Osimertinib Drugs Customer List
Table 64. Global Osimertinib Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Osimertinib Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Osimertinib Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Osimertinib Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Osimertinib Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Osimertinib Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Osimertinib Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Osimertinib Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Osimertinib Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Osimertinib Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Osimertinib Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Osimertinib Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Osimertinib Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Osimertinib Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AstraZeneca Basic Information, Osimertinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Osimertinib Drugs Product Portfolios and Specifications
Table 80. AstraZeneca Osimertinib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Osimertinib Drugs
Figure 2. Osimertinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Osimertinib Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Osimertinib Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg
Figure 10. Product Picture of 80mg
Figure 11. Global Osimertinib Drugs Sales Market Share by Type in 2022
Figure 12. Global Osimertinib Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Osimertinib Drugs Consumed in Hospital
Figure 14. Global Osimertinib Drugs Market: Hospital (2018-2023) & (K Units)
Figure 15. Osimertinib Drugs Consumed in Drugs Store
Figure 16. Global Osimertinib Drugs Market: Drugs Store (2018-2023) & (K Units)
Figure 17. Global Osimertinib Drugs Sales Market Share by Application (2022)
Figure 18. Global Osimertinib Drugs Revenue Market Share by Application in 2022
Figure 19. Osimertinib Drugs Sales Market by Company in 2022 (K Units)
Figure 20. Global Osimertinib Drugs Sales Market Share by Company in 2022
Figure 21. Osimertinib Drugs Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Osimertinib Drugs Revenue Market Share by Company in 2022
Figure 23. Global Osimertinib Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Osimertinib Drugs Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Osimertinib Drugs Sales 2018-2023 (K Units)
Figure 26. Americas Osimertinib Drugs Revenue 2018-2023 ($ Millions)
Figure 27. APAC Osimertinib Drugs Sales 2018-2023 (K Units)
Figure 28. APAC Osimertinib Drugs Revenue 2018-2023 ($ Millions)
Figure 29. Europe Osimertinib Drugs Sales 2018-2023 (K Units)
Figure 30. Europe Osimertinib Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Osimertinib Drugs Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Osimertinib Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Americas Osimertinib Drugs Sales Market Share by Country in 2022
Figure 34. Americas Osimertinib Drugs Revenue Market Share by Country in 2022
Figure 35. Americas Osimertinib Drugs Sales Market Share by Type (2018-2023)
Figure 36. Americas Osimertinib Drugs Sales Market Share by Application (2018-2023)
Figure 37. United States Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Osimertinib Drugs Sales Market Share by Region in 2022
Figure 42. APAC Osimertinib Drugs Revenue Market Share by Regions in 2022
Figure 43. APAC Osimertinib Drugs Sales Market Share by Type (2018-2023)
Figure 44. APAC Osimertinib Drugs Sales Market Share by Application (2018-2023)
Figure 45. China Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Osimertinib Drugs Sales Market Share by Country in 2022
Figure 53. Europe Osimertinib Drugs Revenue Market Share by Country in 2022
Figure 54. Europe Osimertinib Drugs Sales Market Share by Type (2018-2023)
Figure 55. Europe Osimertinib Drugs Sales Market Share by Application (2018-2023)
Figure 56. Germany Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Osimertinib Drugs Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Osimertinib Drugs Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Osimertinib Drugs Sales Market Share by Application (2018-2023)
Figure 65. Egypt Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Osimertinib Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Osimertinib Drugs in 2022
Figure 71. Manufacturing Process Analysis of Osimertinib Drugs
Figure 72. Industry Chain Structure of Osimertinib Drugs
Figure 73. Channels of Distribution
Figure 74. Global Osimertinib Drugs Sales Market Forecast by Region (2024-2029)
Figure 75. Global Osimertinib Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Osimertinib Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Osimertinib Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Osimertinib Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Osimertinib Drugs Revenue Market Share Forecast by Application (2024-2029)